Orphan designation: Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor (lisocabtagene maraleucel), Treatment of follicular lymphoma, 25/05/2018, Positive

SEMrush
Orphan designation: Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor (lisocabtagene maraleucel), Treatment of follicular lymphoma, 25/05/2018, Positive
[automaticbacklinks]